PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 27807077-4 2017 Both tomato- and lycopene-fed TRAMP:Bco2-/- mice had significantly greater serum concentrations of total, 5-cis, other cis, and all-trans lycopene than TRAMP:Bco2+/+ mice. Lycopene 17-25 beta-carotene oxygenase 2 Mus musculus 36-40 29266812-1 2018 SCOPE: Beta-carotene-15,15"-oxygenase (BCO1) and beta-carotene-9",10"-oxygenase (BCO2) metabolize lycopene to biologically active metabolites, which can ameliorate nonalcoholic fatty liver disease (NAFLD). Lycopene 98-106 beta-carotene oxygenase 2 Mus musculus 81-85 34964896-9 2022 The impact of Bco2 genotype was limited to a subset of lycopene-impacted genes (Apc, Mto1, Nfkb1, and Rbm39). Lycopene 55-63 beta-carotene oxygenase 2 Mus musculus 14-18 27807077-4 2017 Both tomato- and lycopene-fed TRAMP:Bco2-/- mice had significantly greater serum concentrations of total, 5-cis, other cis, and all-trans lycopene than TRAMP:Bco2+/+ mice. Lycopene 17-25 beta-carotene oxygenase 2 Mus musculus 158-162 27807077-7 2017 Overall, dietary tomato and lycopene inhibited the progression of prostate cancer in TRAMP in a Bco2 genotype-specific manner, potentially implicating the anticancer activity of lycopene cleavage products. Lycopene 28-36 beta-carotene oxygenase 2 Mus musculus 96-100 25293877-2 2014 We recently showed that apo-10"-lycopenoic acid, a lycopene metabolite generated by beta-carotene-9",10"-oxygenase (BCO2), inhibited carcinogen-initiated, high-fat diet (HFD)-promoted liver inflammation, and hepatic tumorigenesis development. Lycopene 51-59 beta-carotene oxygenase 2 Mus musculus 116-120 25644347-5 2015 RESULTS: Lycopene or APO10LA supplementation reduced hepatic steatosis incidence (78% and 72%, respectively) and severity in BCO2-KO male mice. Lycopene 9-17 beta-carotene oxygenase 2 Mus musculus 125-129 25644347-11 2015 CONCLUSIONS: Our data suggest that lycopene and APO10LA inhibit HSFD-induced steatosis in BCO2-KO male mice through differential mechanisms. Lycopene 35-43 beta-carotene oxygenase 2 Mus musculus 90-94 25293877-7 2014 Lycopene supplementation in BCO2-KO mice suppressed oncogenic signals, including Met mRNA, beta-catenin protein, and mTOR complex 1 activation, which was associated with increased hepatic microRNA (miR)-199a/b and miR214 levels. Lycopene 0-8 beta-carotene oxygenase 2 Mus musculus 28-32 25293877-8 2014 These results provided novel experimental evidence that dietary lycopene can prevent HFD-promoted HCC incidence and multiplicity in mice, and may elicit different mechanisms depending on BCO2 expression. Lycopene 64-72 beta-carotene oxygenase 2 Mus musculus 187-191 25293877-6 2014 In contrast, the protective effects of lycopene in BCO2-KO but not in wild-type mice were associated with reduced hepatic endoplasmic reticulum stress-mediated unfolded protein response (ER(UPR)), through decreasing ER(UPR)-mediated protein kinase RNA-activated like kinase-eukaryotic initiation factor 2alpha activation, and inositol requiring 1alpha-X-box-binding protein 1 signaling. Lycopene 39-47 beta-carotene oxygenase 2 Mus musculus 51-55 16672231-5 2006 The cleavage activity of ferret CMO2 was higher toward lycopene cis-isomers as compared with beta-carotene as substrate. Lycopene 55-63 beta-carotene oxygenase 2 Mus musculus 32-36 16672231-3 2006 Here we provide information on the biochemical characterization of CMO2 of the ferret, a model for human carotenoid metabolism, in terms of the kinetic analysis of beta-carotene/lycopene cleavage into beta-apo-10"-carotenal/apo-10"-lycopenal in vitro and the formation of apo-10"-lycopenoids in ferrets in vivo. Lycopene 178-186 beta-carotene oxygenase 2 Mus musculus 67-71 16672231-7 2006 Furthermore, all-trans-lycopene supplementation in ferrets resulted in significant accumulation of cis-isomers of lycopene and the formation of apo-10"-lycopenol, as well as up-regulation of the CMO2 expression in lung tissues. Lycopene 13-31 beta-carotene oxygenase 2 Mus musculus 195-199 16672231-7 2006 Furthermore, all-trans-lycopene supplementation in ferrets resulted in significant accumulation of cis-isomers of lycopene and the formation of apo-10"-lycopenol, as well as up-regulation of the CMO2 expression in lung tissues. Lycopene 23-31 beta-carotene oxygenase 2 Mus musculus 195-199 16672231-9 2006 Our finding of bioconversion of cis-isomers of lycopene into apo-10"-lycopenoids by CMO2 is significant because cis-isomers of lycopene are a predominant form of lycopene in mammalian tissues and apo-lycopenoids may have specific biological activities related to human health. Lycopene 47-55 beta-carotene oxygenase 2 Mus musculus 84-88 16672231-9 2006 Our finding of bioconversion of cis-isomers of lycopene into apo-10"-lycopenoids by CMO2 is significant because cis-isomers of lycopene are a predominant form of lycopene in mammalian tissues and apo-lycopenoids may have specific biological activities related to human health. Lycopene 127-135 beta-carotene oxygenase 2 Mus musculus 84-88 16672231-9 2006 Our finding of bioconversion of cis-isomers of lycopene into apo-10"-lycopenoids by CMO2 is significant because cis-isomers of lycopene are a predominant form of lycopene in mammalian tissues and apo-lycopenoids may have specific biological activities related to human health. Lycopene 127-135 beta-carotene oxygenase 2 Mus musculus 84-88